Poul Henning Jensen is a full Professor at Aarhus University , affiliated with both the Department of Biomedicine (Skou-building) and the Department of Molecular Biology and Genetics (Neurobiology section). Research Interests : Neurobiology of synucleinopathies Molecular mechanisms in Parkinson's disease Protein aggregation and propagation Calcium signaling in neurodegeneration Neuroinflammatory responses Scientific Activities : His work focuses on α-synuclein biology, covering structural analysis, aggregation pathways, and their pathological consequences. Recent studies include novel detection methods for early α-synuclein pathology mechanisms of neurotoxicity sex-specific neuroprotective factors and protein interaction networks in disease models . Scientific Awards : Recipient of at least one significant research prize Collaborations : Works with international teams on clinical trials targeting α-synuclein and coordinates multiple studies on neurodegenerative disease mechanisms.
Robert Krarup Feidenhans'l is a Professor in X-ray Physics and Visiting Professor in Condensed Matter Physics at the Niels Bohr Institute, University of Copenhagen. His research bridges fundamental physics with practical applications in materials characterization, biological imaging, and nanotechnology through advanced X-ray techniques. Feidenhans'l earned his Master's degree in Physics and Mathematics in 1983 and his Ph.D. in Physics from the University of Aarhus in 1986, where he was awarded the A. Angelo prize. His career progressed from staff scientist at Risø National Laboratory to leadership positions including Head of the Materials Research Department at Risø, Professor at the Niels Bohr Institute, Vice Institute Leader for Research, and Interim Institute Leader. His research interests span Surface and Interface Science, X-ray Physics, Synchrotron Radiation, Materials Science, Crystallography, Nanoscience, and Biophysics. His work demonstrates a progression from fundamental materials research toward innovative applications of X-ray techniques in biological systems while maintaining strong contributions to materials characterization. With approximately 140 publications and an h-index of 31, his research has garnered over 3,940 citations as of 2012, reflecting significant impact across multiple disciplines. Feidenhans'l has held prestigious leadership positions including Chairman of the Council of European Synchrotron Radiation Facility (2006-2010, with a €90M annual budget and 600 employees), Chairman of the European XFEL Council (2010-present, overseeing a €1.1 billion construction project), and Director of DANSYNC/DANSCATT. He has served on advisory committees for major international facilities including MAXLAB in Lund, HASYLAB/DESY, and the LCLS in Stanford. As an educator, Feidenhans'l has supervised approximately 21 master's students and 15 Ph.D. students, currently guiding 6 Ph.D. and 8 master's students. He teaches core courses including Introduction to Solid State Physics, Experimental X-ray Physics, and Structural Tools in NanoScience. His leadership extends to chairing the PhD Committee at the Faculty of Sciences and serving on the Academic Council of the Faculty of Science at the University of Copenhagen. He has co-organized numerous international conferences and summer schools, including the Nordic Summerschool on Synchrotron Radiation and the International Conference on Solid Films and Surfaces.
Roberto Andrés Meneses Valdés is a Postdoctoral Researcher at the Department of Nutrition, Exercise and Sports, University of Copenhagen, working within The August Krogh Section for Molecular Physiology. His research is centered on molecular mechanisms in exercise physiology and metabolic disease, with a specific focus on redox signaling pathways. His primary research interests include: Redox biology in skeletal and cardiac muscle Mitochondrial hydrogen peroxide dynamics Oxidative stress in metabolic disorders NADPH oxidase function in tissue adaptation Insulin resistance mechanisms Analysis of his recent publications reveals a consistent focus on hydrogen peroxide signaling in muscle physiology, with particular emphasis on how redox mechanisms influence metabolic adaptations in both healthy and disease states. His work bridges molecular physiology with exercise science, often employing chemogenetic approaches to manipulate specific redox pathways in vivo. His research is conducted within The August Krogh Section for Molecular Physiology, which maintains active collaborations with multiple international research groups as evidenced by his co-authorship patterns across diverse institutions.
Lisette Salvesen serves as a Clinical Associate Professor in the Department of Clinical Medicine specializing in Neurology at the University of Copenhagen. Her research program focuses on neurodegenerative disorders with particular emphasis on Parkinson's Disease, Multiple System Atrophy, and related synucleinopathies. Her primary research interests include: Alpha-synuclein pathology and detection methods Autoantibody profiles across neurodegenerative conditions Neuroinflammation mechanisms in neurological disorders Biomarker development for disease diagnosis and progression Therapeutic response evaluation in movement disorders Proteomic analysis of neurodegenerative brain tissue Dr. Salvesen's publication record demonstrates a consistent research trajectory examining immunological aspects of neurodegenerative diseases. Her recent work has increasingly focused on comparative analysis of autoantibody responses across different conditions, development of standardized detection methods for proteinopathies, and investigation of potential biomarkers in cerebrospinal fluid and plasma. This research has been published in high-impact journals including PLoS ONE, Journal of Neuroinflammation, and Cellular and Molecular Life Sciences. Her scholarly contributions have received attention in the scientific community, with multiple publications being covered by news outlets and accumulating significant readership on academic platforms like Mendeley. Several of her papers have received citations in Scopus, indicating growing scholarly impact in the field of neurodegenerative disease research. Dr. Salvesen maintains active collaborations with researchers across multiple institutions, as evidenced by her co-authorship on numerous publications with diverse research teams. Her work bridges clinical neurology with immunological investigation, contributing to a better understanding of the complex mechanisms underlying neurodegenerative disorders.
Páll Karlsson is an Associate Professor at the Department of Clinical Medicine , Aarhus University, specializing in neuropathic pain , diabetic neuropathy , and nerve fiber pathology . His research focuses on clinical applications in pain management and diabetes-related neurological complications. His work includes longitudinal studies on heat sensation anomalies, cohort analyses of Parkinson’s disease, and consensus guidelines for neuropathic pain research. He actively participates in international collaborations and clinical trial design. He has received prestigious awards, including the Danish Diabetes Academy Scientist Award and Mogens Fog Prize , and contributes to peer review and academic events. Key Research Areas : Diabetic Neuropathy, Peripheral Neuropathy, Neuropathic Pain, Nerve Fiber Pathology, Parkinson’s Disease, Clinical Trial Design Scientific Awards : Danish Diabetes Academy Scientist Award (2020) Mogens Fog Prisen (2016) Scandinavian Association for the Study of Pain (SASP) Poster Prize (2015)
Rasmus Rydbirk is an Academic staff member at the Department of Biochemistry and Molecular Biology at University of Southern Denmark, with additional affiliations at Functional Genomic Studies and Metabolism and ATLAS - Center for Functional Genomic Studies of Tissue Plasticity. He maintains an active research profile with publications spanning neuroscience, proteomics, and molecular biology. Dr. Rydbirk's research primarily focuses on Multiple System Atrophy (MSA), a rare neurodegenerative disorder, with additional work in proteome analysis and epigenetic mechanisms. His fingerprint analysis reveals strong expertise in Neuroscience (100% for Multiple System Atrophy), Proteome analysis (50%), Shy-Drager Syndrome (50%), and specialized knowledge in Fibrinogen, Light Chain, Blood Plasma, 5-Methylcytosine, and Cerebrospinal Fluid research. His recent publications demonstrate a clear trajectory in neurodegenerative disease research, particularly MSA, with a methodological emphasis on advanced proteomics and epigenetic analysis. The 2024 Nature Biotechnology paper indicates significant contributions to mass spectrometry technology, while his neuroscience work shows consistent focus on understanding the molecular mechanisms underlying MSA pathology. Dr. Rydbirk maintains active research collaborations internationally, as indicated by the country/region level collaboration map showing connections across multiple continents. His work has garnered substantial academic attention with over 100 citations for his Nature Biotechnology paper alone.
Yousif Subhi serves as Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with primary clinical affiliation at Copenhagen University Hospital (Region Hovedstaden). His research focuses on retinal diseases within ophthalmology, particularly age-related macular degeneration, diabetic retinopathy, and uveitis, leveraging both clinical studies and computational approaches. His research program emphasizes translational applications in ophthalmology, with significant contributions to understanding age-related macular degeneration pathophysiology and treatment. Key interests include choriocapillaris imaging using optical coherence tomography angiography, Charles Bonnet syndrome in geographic atrophy patients, and personalized medicine approaches connecting systemic conditions like periodontitis with ocular diseases. He actively develops AI-based diagnostic tools for diabetic retinopathy and investigates therapeutic windows in inflammatory eye conditions. Analysis of his 2025 publications reveals a strong emphasis on systematic reviews and consensus-building in age-related macular degeneration management, with multiple network meta-analyses evaluating anti-VEGF therapies. His work demonstrates interdisciplinary collaboration across ophthalmology, dentistry, and computer science, while addressing practical clinical challenges through curriculum development for AMD education and exploration of early intervention windows in uveitis-related complications.
Anne-Mette Hejl serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic appointment is specifically within the Neurology division, where she conducts research at the intersection of neurology, immunology, and advanced imaging techniques. Her institutional affiliation includes Region Hovedstaden (Capital Region of Denmark), as indicated by her regionh.dk email address. Dr. Hejl's research focuses on neurodegenerative disorders, particularly Parkinson's disease and related synucleinopathies. Her work spans multiple domains including neuroimaging techniques (particularly 7 Tesla MRI), autoantibody profiling, and the investigation of pathological mechanisms in neurodegenerative conditions. She has made significant contributions to understanding the structural changes in Parkinson's disease, diagnostic approaches for atypical parkinsonism, and the role of autoimmunity in neurodegenerative processes. Her publication record shows a consistent trend toward interdisciplinary research that bridges clinical neurology with biochemical and immunological approaches. Recent work has explored advanced imaging techniques for Parkinson's disease diagnosis, standardized detection methods for synucleinopathies, and the complex relationships between autoantibodies and neurodegenerative conditions. Her research demonstrates a strong emphasis on developing more accurate diagnostic tools and understanding disease mechanisms at molecular and structural levels. Dr. Hejl maintains active collaborations with numerous researchers across Denmark and internationally, as evidenced by her extensive co-authorship network. Her work has been disseminated through high-impact journals in neurology, neuroscience, and medical imaging fields. While specific grant information isn't detailed in the available materials, her research output suggests participation in multiple collaborative projects investigating neurodegenerative disorders. Her laboratory work appears to focus on neuroimaging analysis, biomarker discovery, and immunological aspects of neurodegenerative diseases. The collaborative nature of her publications indicates she works within multidisciplinary teams that likely include neurologists, imaging specialists, immunologists, and biochemists working together to advance understanding of Parkinson's disease and related conditions.
David Paul Drucker Woldbye is an Associate Professor at the Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, where he leads the Laboratory of Neural Plasticity at the Mærsk Tower. His research focuses on neuropeptides, particularly neuropeptide Y (NPY), and their therapeutic potential in epilepsy, addiction, and neuropsychiatric disorders through gene therapy approaches. His primary research interests include neuropsychiatry, neuropeptides, animal models of neuropsychiatric disorders, addiction, gene therapy, viral vectors, epilepsy, affective disorders, and electroconvulsive treatment. Woldbye's work combines molecular neuroscience with translational approaches, utilizing viral vector-mediated gene therapy, chemogenetics (DREADDs), behavioral rodent models, and advanced neuroanatomical techniques. Analysis of his recent publications reveals a strong emphasis on neuropeptide systems (particularly NPY and somatostatin) in seizure modulation, anxiety, pain, and addiction. His research spans molecular mechanisms to behavioral outcomes, with significant contributions to understanding how neuropeptide-based therapies can modulate neural circuits involved in neurological and psychiatric disorders. Recent work has expanded into Alzheimer's disease modeling, collagen VI in epilepsy, and dopamine transporter mechanisms. Grethe and Hans Lundbeck Scholarship (1990-1991) Gold medal in Essay Competition of University of Copenhagen in Medicine (1991) The Ole Rafaelsen Award in Biological Psychiatry and Psychopharmacology (2000) Dana Glue annual prize for ADHD research (2018) Communicator of the month at the Department of Neuroscience and Pharmacology (2013) Woldbye has supervised 17 PhD students (9 as main supervisor) and has served as evaluator for 17 PhD theses. His research is currently funded by the Lundbeck Foundation, NOVO Foundation, and Innovation Foundation. He has co-founded three biotech companies (CombiGene, Panion, and RetiPharma) translating his research into clinical applications. His laboratory includes 2 post-docs, 5 PhD students, 2 research assistants, and 5 master students. The Laboratory of Neural Plasticity focuses on gene therapeutic regulation of neuropeptides in experimental models of epilepsy and other neuropsychiatric disorders. The lab has expertise in viral vector delivery, behavioral phenotyping, in situ hybridization, receptor autoradiography, and functional binding assays. Woldbye's translational work has led to multiple patent applications and collaborations with industry partners.
Eva Løbner Lund is an Associate Professor and Senior Consultant Neuropathologist at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. She maintains a dual role as a clinical neuropathologist at Copenhagen University Hospital (Region Hovedstaden) where she practices as a Senior Consultant. Her work bridges clinical neuropathology with cutting-edge research in neurodegenerative disorders, focusing particularly on diagnostic methodologies for conditions like Parkinson's disease and Creutzfeldt-Jakob disease. Dr. Lund's research interests center on neuropathology with special emphasis on neurodegenerative disorders characterized by protein misfolding. She has developed expertise in detecting pathological proteins such as α-synuclein and prions across various biological samples including CSF, skin, and olfactory mucosa. Her work aims to establish standardized diagnostic protocols that can be implemented across clinical settings to improve early detection of neurodegenerative conditions. This research has significant implications for patient stratification and potential therapeutic interventions. Analysis of Dr. Lund's recent publication record reveals a consistent focus on developing and validating diagnostic assays for neurodegenerative diseases. Her work spans from fundamental research on disease mechanisms to practical clinical applications of diagnostic methods. A notable trend is her participation in international multi-center studies that aim to standardize detection protocols for pathological proteins across different healthcare systems. Her 2025 publications particularly highlight advances in uniform seeding amplification assays for α-synuclein detection across multiple sample types. Dr. Lund maintains active collaborations with research institutions across Europe and North America, contributing her neuropathology expertise to large-scale studies on neurodegenerative diseases. Her clinical position at Copenhagen University Hospital provides essential real-world context for her research, ensuring that diagnostic developments address actual clinical challenges faced by neuropathologists and neurologists.
Dan Milea serves as an Adjunct Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Ophthalmology. He maintains a dual affiliation with SingHealth in Singapore, where he can be reached at dan.milea@singhealth.com.sg. His primary research address is at Blegdamsvej 3, 2200 København N, Denmark, indicating strong institutional ties to the University of Copenhagen campus. Dr. Milea's research program centers on the intersection of ophthalmology and artificial intelligence, with particular emphasis on neuro-ophthalmic disorders. His work spans optic nerve pathologies, medical imaging analysis, visual prosthetics, and diagnostic technology assessment. He has pioneered AI applications for detecting conditions like optic atrophy, central retinal artery occlusion, and pediatric papilledema through analysis of standard fundus photographs and optical coherence tomography. His publication record shows a clear trajectory toward developing clinically applicable AI diagnostic tools, with 73 research outputs documented. The BONSAI (Brain and Optic Nerve Study with Artificial Intelligence) Group represents his primary research vehicle, producing systems that can discriminate between arteritic and nonarteritic optic neuropathies and identify papilledema in pediatric patients using conventional imaging techniques. Dr. Milea's research impact is evident through widespread academic engagement - his work has been discussed across multiple X (Twitter) platforms, shared on Facebook, covered by news outlets, referenced on Bluesky, and read by researchers on Mendeley. This multi-platform visibility demonstrates significant influence within both specialized ophthalmology communities and broader medical AI research circles.
Isabel Evi Naumann is a Research Fellow at the Biotech Research & Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen, affiliated with the Khodosevich Group under a prestigious Marie Curie Fellowship. Her academic background includes: Master of Science in Biomedicine from the University of Strasbourg (2021-2023), investigating Type 2 cytokines' effects on human neuronal function Bachelor of Science in Molecular Medicine from Friedrich-Alexander University Erlangen-Nürnberg (2017-2021), focusing on alpha-, beta-, and gamma-synuclein characterization Dr. Naumann's research integrates molecular neuroscience with neuroimmunology, specializing in schizophrenia mechanisms, neurodegenerative disorders, and single-cell RNA sequencing applications. Her work bridges cellular immunology and neuronal dysfunction, particularly examining microglial roles in Parkinsonian syndromes through advanced genomic techniques. Her 2022 publication in The Journal of Neuroscience demonstrates expertise at the intersection of neuroinflammation and movement disorders, revealing complex relationships between myeloid cell modulation and disease progression in Multiple System Atrophy models. Key recognition includes: Marie Curie Fellowship for her innovative neuroscience research As a Marie Curie Fellow, she secures competitive research funding while contributing to BRIC's collaborative environment. Her current projects involve single-cell transcriptomics to dissect neuroimmune interactions in psychiatric and neurodegenerative conditions. Dr. Naumann actively contributes to the Khodosevich Group's mission at BRIC, utilizing cutting-edge molecular techniques to investigate neurological disease mechanisms with translational potential.
Takamitsu Watanabe is a Professor at the International Research Center for Neurointelligence (IRCN) at the University of Tokyo, where he leads a research laboratory focused on understanding the neural mechanisms underlying human intelligence and neuropsychiatric conditions. Previously, he served as an Associate Professor at IRCN (2020-2025) and Deputy Team Leader for the Miyashita lab at RIKEN Center for Brain Science (2018-2020). His research spans multiple disciplines within neuroscience, with a particular emphasis on how brain dynamics relate to cognitive functions and disorders. Watanabe received his M.D. from The University of Tokyo in 2007, completed his medical training there, and earned his Ph.D. in 2013 under Professor Yasushi Miyashita as a JSPS Research Fellow. He conducted post-doctoral research with Professor Geraint Rees at University College London under both JSPS and Marie-Curie Research Fellowships. His primary research interests focus on the dynamic nature of human cognition and its neural underpinnings. Watanabe investigates how large-scale brain network architecture, global and local neural dynamics relate to both typical and atypical cognition, with particular emphasis on conditions like autism, schizophrenia, and epilepsy. His work has pioneered the application of energy landscape analysis to understand brain activity patterns, revealing how neural stability and flexibility relate to cognitive functions. Recent research has expanded to examine parallels between brain dynamics in neuropsychiatric conditions and artificial intelligence systems, particularly large language models. Analysis of Watanabe's publication record reveals a consistent focus on neural dynamics as a framework for understanding cognition. His work has evolved from foundational studies on brain network dynamics in autism to more recent investigations of neural mechanisms in Alzheimer's disease and comparative analyses between human brain activity and AI processing. A distinctive thread throughout his research is the innovative application of mathematical and computational approaches to neuroimaging data, particularly energy landscape analysis, to quantify neural dynamics in ways that correlate with behavioral and cognitive measures. NeuroCreative Award RIKEN Excellent Achievement Award JSPS Research Fellowship Marie-Curie Research Fellowship Watanabe actively mentors researchers in his laboratory, including postdoctoral fellows like Dr. Shota Murai (awarded a JSPS post-doc fellowship) and Dr. Agnes Gao, as well as students like Daichi Watanabe. His research is supported by numerous prestigious grants including KAKEN, JSPS, European Council funding, Wellcome Trust, and several Japanese research initiatives including the Moonshot R&D Program and SIP. His laboratory at WPI-IRCN utilizes a multidisciplinary approach combining human behavioral experiments using fMRI, EEG, TMS, TUS and motion capture devices with computational and data science methods. Watanabe's laboratory at the IRCN is a vibrant research environment that brings together neuroscientists, psychologists, and computational scientists. The lab has established collaborations with international institutions, including Brown University (with Professor Sanes) and European research centers. Current research directions include developing non-invasive neural stimulation techniques to modulate brain dynamics in neurodevelopmental conditions, investigating the neural basis of comorbid conditions like ASD/ADHD, and exploring parallels between brain dynamics and AI processing. The lab actively recruits PhD students and postdoctoral researchers, particularly those with computational backgrounds or fellowship support.
Ole Østergaard is a Researcher at the Novo Nordisk Foundation Center for Protein Research within the Faculty of Health and Medical Sciences at the University of Copenhagen. His work focuses on advancing proteomics techniques and applying them to understand disease mechanisms, particularly through the study of extracellular vesicles. His research spans several critical areas in modern biomedical science: Extracellular vesicles and their role in health and disease Proteomics and biomarker discovery using high-resolution mass spectrometry Applications in neurodegenerative diseases and autoimmune conditions Development of novel proteomic methodologies for minimal sample analysis Dr. Østergaard's recent publications demonstrate significant contributions to the field, particularly in cerebrospinal fluid analysis for pediatric CNS cancers, standardization of extracellular vesicle research through the MISEV2023 guidelines, and development of innovative techniques like One-Tip for single-cell proteomics. His work in high-impact journals such as Nature Communications, Nature Biotechnology, and Journal of Extracellular Vesicles reflects his expertise in both technical proteomics and clinical applications. He is actively involved in the Olsen Group at the Center for Protein Research, contributing to cutting-edge research in spatial proteomics, phospho-signaling dynamics, and deep plasma proteome analysis through extracellular vesicle enrichment. His collaborative network spans multiple institutions, as evidenced by his co-authorship on numerous high-impact publications with international researchers.
Louise C P Raun Diederichsen serves as a Clinical Associate Professor at the Department of Clinical Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her clinical specialization focuses on Internal Medicine: Rheumatology, with dual institutional affiliations at Blegdamsvej 9 (2100 Copenhagen Ø) and Blegdamsvej 3 (2200 Copenhagen N) in Denmark. Her research portfolio demonstrates deep expertise in autoimmune rheumatic diseases with particular emphasis on connective tissue disorders and inflammatory myopathies. Key research areas include systemic lupus erythematosus, systemic sclerosis, dermatomyositis, polymyositis, and sporadic inclusion body myositis. Her work frequently explores complications such as cardiovascular risks, cancer associations, and innovative treatment approaches for neuromuscular manifestations. Analysis of her publication trends reveals three dominant research streams: (1) autoimmune disease complications including cancer risks and cardiac outcomes, (2) diagnostic biomarker development for connective tissue diseases, and (3) therapeutic interventions for inflammatory myopathies including physical rehabilitation approaches and targeted treatments. Her recent work shows increasing focus on nationwide cohort studies and translational applications of imaging techniques. Dr. Diederichsen maintains active clinical research collaborations across multiple Danish medical institutions, particularly with Copenhagen University Hospital (Region Hovedstaden) as indicated by her institutional email domain. Her research output demonstrates consistent productivity with publications spanning high-impact rheumatology, neurology, and internal medicine journals.
